Search for Stocks /

πŸ’Š Procter & Gamble Health FY25 Results: β‚Ή125 Dividend for a 9-Month Year β€” Who Needs 12 Months Anyway?

πŸ“Œ At a Glance

P&G Health Ltd (NSE: PGHL) just pulled off a rare feat β€” a 27% PAT growth in just 9 months, all while changing their fiscal year! From July–March, the company posted β‚Ή918 crore in revenue and β‚Ή234 crore in PAT, backed by strong brand plays like Neurobion and Livogen. Oh, and the board’s feeling generous β€” total dividend? β‚Ή125/share.


🧬 Key Highlights

πŸ” Metric9M FY25 (Jul–Mar)YoY Growth
Revenueβ‚Ή918 Cr+8%
PATβ‚Ή234 Cr+27% (14% adj. excl. one-time)
Dividendβ‚Ή125/share🧨 Boom!
  • Q3 FY25 Revenue: β‚Ή304 Cr (+23%)
  • Q3 FY25 PAT: β‚Ή61 Cr (+31%)

πŸ§ͺ Why Only 9 Months?

Because P&G decided 12 months is too mainstream.

Join 10,000+ investors who read this every week.
Become a member